0001562180-22-007175.txt : 20221012
0001562180-22-007175.hdr.sgml : 20221012
20221012183118
ACCESSION NUMBER: 0001562180-22-007175
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221003
FILED AS OF DATE: 20221012
DATE AS OF CHANGE: 20221012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HUGIN ROBERT J
CENTRAL INDEX KEY: 0001232505
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41477
FILM NUMBER: 221307668
MAIL ADDRESS:
STREET 1: C/O THE MEDICINES CO
STREET 2: 8 CAMPUS DR
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Ltd.
CENTRAL INDEX KEY: 0001935979
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
FORMER COMPANY:
FORMER CONFORMED NAME: Biohaven Research Ltd.
DATE OF NAME CHANGE: 20220629
4/A
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4/A
2022-10-03
2022-10-05
false
0001935979
Biohaven Ltd.
BHVN
0001232505
HUGIN ROBERT J
C/O BIOHAVEN LTD.
215 CHURCH STREET
NEW HAVEN
CT
06510
true
false
false
false
Common Shares
2022-10-03
4
F
false
12959.00
7.50
D
12959.00
D
These shares were withheld by the Issuer in connection with share settlement to cover the cost of the stock options.
This amendment is being filed to correct the amount of shares beneficially owned reported in the Form 4 filed on October 5, 2022 (the "Original Form 4"). The Original Form 4 inadvertently incorrectly reported that 3,263 shares were withheld by the Issuer in connection with the share settlement to cover the cost of the stock options; however, as reflected in this amendment, 9,790 shares were withheld by the Issuer in connect with the share settlement to cover the cost of the stock options. There were no other changes made to the information in the Original Form 4.
/s/ George Clark, Attorney-in-Fact
2022-10-12